These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 7389746)

  • 1. Microbiological transformation of 1,2-diphenyl-3,5 dioxo-4-n-butyl pyrazolidine (phenylbutazone).
    Favero J; Winternitz F
    Eur J Drug Metab Pharmacokinet; 1980; 5(1):1-7. PubMed ID: 7389746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Experiments on the effect of 3, 5-dioxo-1, 2-diphenyl-4-n-butyl-pyrazolidine. I. Distribution in organism after a single intravenous injection].
    HEISE ER; KIMBEL KH
    Arzneimittelforschung; 1956 Dec; 6(12):722-4. PubMed ID: 13395933
    [No Abstract]   [Full Text] [Related]  

  • 3. [Experiments on the effect of 3, 5-dioxo-1, 2-diphenyl-4-n-butyl-pyrazolidine in rats. II. Distribution of the drug in the organism after repeated oral doses].
    HEISE ER
    Arzneimittelforschung; 1956 Dec; 6(12):724-6. PubMed ID: 13395934
    [No Abstract]   [Full Text] [Related]  

  • 4. The biotransformation of phenylbutazone (Butazolidin).
    Faigle JW; Dieterle W
    J Int Med Res; 1977; 5 Suppl 2():2-14. PubMed ID: 410685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolism of phenylbutazone in man.
    Dieterle W; Faigle JW; Früh F; Mory H; Theoblad W; Alt KO; Richter WJ
    Arzneimittelforschung; 1976 Apr; 26(4):572-7. PubMed ID: 782467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Penetration of human aqueous humor by 3,5-dioxo-1,2-diphenyl-4-n-butyl-pyrazolidine (butazolidin)].
    MUNICH W
    Albrecht Von Graefes Arch Ophthalmol; 1958; 160(2):181-5. PubMed ID: 13545132
    [No Abstract]   [Full Text] [Related]  

  • 7. [Differentiation of 3,5-dioxo-1,2-diphenyl-4-n-butyl-pyrazolidine (phenylbutazone) and 3,5-dioxo-1,2-diphenyl-4-prenyl-pyrazolidine (prenazone) using reaction chromatography].
    schütz C; Schütz H
    Arzneimittelforschung; 1973 Mar; 23(3):428-31. PubMed ID: 4740130
    [No Abstract]   [Full Text] [Related]  

  • 8. [The effect of 3,5-dioxo-1,2-diphenyl-4-n-butyl pyrazolidine and 3,5-dioxo-1-phenyl-2-p-hydroxyphenyl-4-butyl pyrazolidine on the incorporation of C14-leucine into the blood plasma proteins of the isolated rat liver].
    JUNGBLUT PW
    Arzneimittelforschung; 1959 Sep; 9():549-51. PubMed ID: 14408193
    [No Abstract]   [Full Text] [Related]  

  • 9. [About the glucoside of 1,2-diphenyl-3,5-dioxo-4-n-butyl-pyrazolidine (phenylbutazone)].
    MOREL CJ
    Experientia; 1958 Aug; 14(8):294-5. PubMed ID: 13574145
    [No Abstract]   [Full Text] [Related]  

  • 10. Influence of dietary portein on the disposition and metabolism of phenylbutazone in rats.
    Varma DR
    Can J Physiol Pharmacol; 1980 Mar; 58(3):231-6. PubMed ID: 7378926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disposition and oxidative metabolism of phenylbutazone in man.
    Aarbakke J; Bakke OM; Milde EJ; Davies DS
    Eur J Clin Pharmacol; 1977; 11(5):359-66. PubMed ID: 880975
    [No Abstract]   [Full Text] [Related]  

  • 12. Metabolism of phenylbutazone in rats.
    Alexander DM; Mathew GE; Wilson BJ
    Xenobiotica; 1985 Feb; 15(2):123-8. PubMed ID: 4002734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acetanilide oxidation in phenylbutazone-associated hypoplastic anaemia.
    Cunningham JL; Leyland MJ; Delamore IW; Evans DA
    Br Med J; 1974 Aug; 3(5926):313-7. PubMed ID: 4411815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of 3,5-dioxo-1,2-diphenyl-4-n-butyl-pyrazolidine on phosphatases. 2].
    OHLMEYER P; KROMER H
    Arzneimittelforschung; 1958 Apr; 8(4):247-8. PubMed ID: 13535368
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effect of 3, 5-dioxo-1, 2-diphenyl-4-n-butyl-pyrazolidine on phosphatases].
    HAHN E; PLATE B
    Arzneimittelforschung; 1956 Dec; 6(12):728-9. PubMed ID: 13395936
    [No Abstract]   [Full Text] [Related]  

  • 16. [Painful shoulder: treatment by 3,5-dioxo-1,2-diphenyl-4-n-butyl-pyrazolidine].
    LEITAO A
    Hospital (Rio J); 1958 Sep; 54(3):335-8. PubMed ID: 13586748
    [No Abstract]   [Full Text] [Related]  

  • 17. The metabolism of phenylbutazone in the rat.
    Bakke OM; Draffan GH; Davies DS
    Xenobiotica; 1974 Apr; 4(4):237-54. PubMed ID: 4603132
    [No Abstract]   [Full Text] [Related]  

  • 18. Mass spectral and pyrolytic behavior of the two main products of phenylbutazone degradation: simulation of unusual mass spectral fragmentation.
    Awang DV; Vincent A
    J Pharm Sci; 1976 Jan; 65(1):68-70. PubMed ID: 1255438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Protein binding of 3, 5-dioxo-1, 2-diphenyl-4-n-butyl-pyrazolidine and several other drugs].
    WUNDERLY C
    Arzneimittelforschung; 1956 Dec; 6(12):731-4. PubMed ID: 13395938
    [No Abstract]   [Full Text] [Related]  

  • 20. [The mechanism of action of 3,5-dioxo-1,2-diphenyl-4-n-butyl-pyrazolidine; complex forming ability of this compound and effects on diphosphopyridine nucleotide-dependent zinc enzymes].
    WALLENFELS K; SUND H
    Arzneimittelforschung; 1959 Feb; 9(2):81-9. PubMed ID: 13638188
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.